img

Global Antihemophilic Factor Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Antihemophilic Factor Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Antihemophilic Factor Drug is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding.
Antihemophilic Factor Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antihemophilic Factor Drug market is projected to reach US$ 796 million in 2029, increasing from US$ 541 million in 2022, with the CAGR of 6.1% during the period of 2024 to 2029. Demand from Adult and Pediatric are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antihemophilic Factor Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bayer
Takeda
Novo Nordisk
Pfizer
Grifols
CSL Behring
Sanofi
Cigna
Octapharma
GC Pharma
Hualan Biological Engineering
Shanghai RAAS blood products
Segment by Type
250 IU
500 IU
1000 IU
1500 IU
2000 IU
3000 IU
4000 IU
Other potencies

Segment by Application


Adult
Pediatric

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Antihemophilic Factor Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antihemophilic Factor Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antihemophilic Factor Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Antihemophilic Factor Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antihemophilic Factor Drug introduction, etc. Antihemophilic Factor Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Antihemophilic Factor Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Antihemophilic Factor Drug Market Overview
1.1 Antihemophilic Factor Drug Product Overview
1.2 Antihemophilic Factor Drug Market Segment by Type
1.2.1 250 IU
1.2.2 500 IU
1.2.3 1000 IU
1.2.4 1500 IU
1.2.5 2000 IU
1.2.6 3000 IU
1.2.7 4000 IU
1.2.8 Other potencies
1.3 Global Antihemophilic Factor Drug Market Size by Type
1.3.1 Global Antihemophilic Factor Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Antihemophilic Factor Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Antihemophilic Factor Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antihemophilic Factor Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Antihemophilic Factor Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Antihemophilic Factor Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Antihemophilic Factor Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Antihemophilic Factor Drug Sales Breakdown by Type (2018-2024)
2 Global Antihemophilic Factor Drug Market Competition by Company
2.1 Global Top Players by Antihemophilic Factor Drug Sales (2018-2024)
2.2 Global Top Players by Antihemophilic Factor Drug Revenue (2018-2024)
2.3 Global Top Players by Antihemophilic Factor Drug Price (2018-2024)
2.4 Global Top Manufacturers Antihemophilic Factor Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antihemophilic Factor Drug Market Competitive Situation and Trends
2.5.1 Antihemophilic Factor Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Antihemophilic Factor Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antihemophilic Factor Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
2.8 Key Manufacturers Antihemophilic Factor Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antihemophilic Factor Drug Status and Outlook by Region
3.1 Global Antihemophilic Factor Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antihemophilic Factor Drug Historic Market Size by Region
3.2.1 Global Antihemophilic Factor Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Antihemophilic Factor Drug Sales in Value by Region (2018-2024)
3.2.3 Global Antihemophilic Factor Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Antihemophilic Factor Drug Forecasted Market Size by Region
3.3.1 Global Antihemophilic Factor Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Antihemophilic Factor Drug Sales in Value by Region (2024-2029)
3.3.3 Global Antihemophilic Factor Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antihemophilic Factor Drug by Application
4.1 Antihemophilic Factor Drug Market Segment by Application
4.1.1 Adult
4.1.2 Pediatric
4.2 Global Antihemophilic Factor Drug Market Size by Application
4.2.1 Global Antihemophilic Factor Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Antihemophilic Factor Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Antihemophilic Factor Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antihemophilic Factor Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Antihemophilic Factor Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Antihemophilic Factor Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Antihemophilic Factor Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Antihemophilic Factor Drug Sales Breakdown by Application (2018-2024)
5 North America Antihemophilic Factor Drug by Country
5.1 North America Antihemophilic Factor Drug Historic Market Size by Country
5.1.1 North America Antihemophilic Factor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antihemophilic Factor Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Antihemophilic Factor Drug Sales in Value by Country (2018-2024)
5.2 North America Antihemophilic Factor Drug Forecasted Market Size by Country
5.2.1 North America Antihemophilic Factor Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Antihemophilic Factor Drug Sales in Value by Country (2024-2029)
6 Europe Antihemophilic Factor Drug by Country
6.1 Europe Antihemophilic Factor Drug Historic Market Size by Country
6.1.1 Europe Antihemophilic Factor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antihemophilic Factor Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Antihemophilic Factor Drug Sales in Value by Country (2018-2024)
6.2 Europe Antihemophilic Factor Drug Forecasted Market Size by Country
6.2.1 Europe Antihemophilic Factor Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Antihemophilic Factor Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Antihemophilic Factor Drug by Region
7.1 Asia-Pacific Antihemophilic Factor Drug Historic Market Size by Region
7.1.1 Asia-Pacific Antihemophilic Factor Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antihemophilic Factor Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Antihemophilic Factor Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Antihemophilic Factor Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Antihemophilic Factor Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antihemophilic Factor Drug Sales in Value by Region (2024-2029)
8 Latin America Antihemophilic Factor Drug by Country
8.1 Latin America Antihemophilic Factor Drug Historic Market Size by Country
8.1.1 Latin America Antihemophilic Factor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antihemophilic Factor Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Antihemophilic Factor Drug Sales in Value by Country (2018-2024)
8.2 Latin America Antihemophilic Factor Drug Forecasted Market Size by Country
8.2.1 Latin America Antihemophilic Factor Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antihemophilic Factor Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Antihemophilic Factor Drug by Country
9.1 Middle East and Africa Antihemophilic Factor Drug Historic Market Size by Country
9.1.1 Middle East and Africa Antihemophilic Factor Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antihemophilic Factor Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Antihemophilic Factor Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Antihemophilic Factor Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Antihemophilic Factor Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antihemophilic Factor Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bayer
10.1.1 Bayer Company Information
10.1.2 Bayer Introduction and Business Overview
10.1.3 Bayer Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Bayer Antihemophilic Factor Drug Products Offered
10.1.5 Bayer Recent Development
10.2 Takeda
10.2.1 Takeda Company Information
10.2.2 Takeda Introduction and Business Overview
10.2.3 Takeda Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Takeda Antihemophilic Factor Drug Products Offered
10.2.5 Takeda Recent Development
10.3 Novo Nordisk
10.3.1 Novo Nordisk Company Information
10.3.2 Novo Nordisk Introduction and Business Overview
10.3.3 Novo Nordisk Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Novo Nordisk Antihemophilic Factor Drug Products Offered
10.3.5 Novo Nordisk Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Antihemophilic Factor Drug Products Offered
10.4.5 Pfizer Recent Development
10.5 Grifols
10.5.1 Grifols Company Information
10.5.2 Grifols Introduction and Business Overview
10.5.3 Grifols Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Grifols Antihemophilic Factor Drug Products Offered
10.5.5 Grifols Recent Development
10.6 CSL Behring
10.6.1 CSL Behring Company Information
10.6.2 CSL Behring Introduction and Business Overview
10.6.3 CSL Behring Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 CSL Behring Antihemophilic Factor Drug Products Offered
10.6.5 CSL Behring Recent Development
10.7 Sanofi
10.7.1 Sanofi Company Information
10.7.2 Sanofi Introduction and Business Overview
10.7.3 Sanofi Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Sanofi Antihemophilic Factor Drug Products Offered
10.7.5 Sanofi Recent Development
10.8 Cigna
10.8.1 Cigna Company Information
10.8.2 Cigna Introduction and Business Overview
10.8.3 Cigna Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Cigna Antihemophilic Factor Drug Products Offered
10.8.5 Cigna Recent Development
10.9 Octapharma
10.9.1 Octapharma Company Information
10.9.2 Octapharma Introduction and Business Overview
10.9.3 Octapharma Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Octapharma Antihemophilic Factor Drug Products Offered
10.9.5 Octapharma Recent Development
10.10 GC Pharma
10.10.1 GC Pharma Company Information
10.10.2 GC Pharma Introduction and Business Overview
10.10.3 GC Pharma Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 GC Pharma Antihemophilic Factor Drug Products Offered
10.10.5 GC Pharma Recent Development
10.11 Hualan Biological Engineering
10.11.1 Hualan Biological Engineering Company Information
10.11.2 Hualan Biological Engineering Introduction and Business Overview
10.11.3 Hualan Biological Engineering Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Hualan Biological Engineering Antihemophilic Factor Drug Products Offered
10.11.5 Hualan Biological Engineering Recent Development
10.12 Shanghai RAAS blood products
10.12.1 Shanghai RAAS blood products Company Information
10.12.2 Shanghai RAAS blood products Introduction and Business Overview
10.12.3 Shanghai RAAS blood products Antihemophilic Factor Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Shanghai RAAS blood products Antihemophilic Factor Drug Products Offered
10.12.5 Shanghai RAAS blood products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antihemophilic Factor Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antihemophilic Factor Drug Industrial Chain Analysis
11.4 Antihemophilic Factor Drug Market Dynamics
11.4.1 Antihemophilic Factor Drug Industry Trends
11.4.2 Antihemophilic Factor Drug Market Drivers
11.4.3 Antihemophilic Factor Drug Market Challenges
11.4.4 Antihemophilic Factor Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antihemophilic Factor Drug Distributors
12.3 Antihemophilic Factor Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 250 IU
Table 2. Major Company of 500 IU
Table 3. Major Company of 1000 IU
Table 4. Major Company of 1500 IU
Table 5. Major Company of 2000 IU
Table 6. Major Company of 3000 IU
Table 7. Major Company of 4000 IU
Table 8. Major Company of Other potencies
Table 9. Global Antihemophilic Factor Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Antihemophilic Factor Drug Sales by Type (2018-2024) & (K Units)
Table 11. Global Antihemophilic Factor Drug Sales Market Share in Volume by Type (2018-2024)
Table 12. Global Antihemophilic Factor Drug Sales by Type (2018-2024) & (US& Million)
Table 13. Global Antihemophilic Factor Drug Market Share in Value by Type (2018-2024)
Table 14. Global Antihemophilic Factor Drug Price by Type (2018-2024) & (USD/Unit)
Table 15. Global Antihemophilic Factor Drug Sales by Type (2024-2029) & (K Units)
Table 16. Global Antihemophilic Factor Drug Sales Market Share in Volume by Type (2024-2029)
Table 17. Global Antihemophilic Factor Drug Sales by Type (2024-2029) & (US$ Million)
Table 18. Global Antihemophilic Factor Drug Sales Market Share in Value by Type (2024-2029)
Table 19. Global Antihemophilic Factor Drug Price by Type (2024-2029) & (USD/Unit)
Table 20. North America Antihemophilic Factor Drug Sales by Type (2018-2024) & (K Units)
Table 21. North America Antihemophilic Factor Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Europe Antihemophilic Factor Drug Sales (K Units) by Type (2018-2024)
Table 23. Europe Antihemophilic Factor Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Asia-Pacific Antihemophilic Factor Drug Sales (K Units) by Type (2018-2024)
Table 25. Asia-Pacific Antihemophilic Factor Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Latin America Antihemophilic Factor Drug Sales (K Units) by Type (2018-2024)
Table 27. Latin America Antihemophilic Factor Drug Sales by Type (2018-2024) & (US$ Million)
Table 28. Middle East and Africa Antihemophilic Factor Drug Sales (K Units) by Type (2018-2024)
Table 29. Middle East and Africa Antihemophilic Factor Drug Sales by Type (2018-2024) & (US$ Million)
Table 30. Global Antihemophilic Factor Drug Sales by Company (2018-2024) & (K Units)
Table 31. Global Antihemophilic Factor Drug Sales Share by Company (2018-2024)
Table 32. Global Antihemophilic Factor Drug Revenue by Company (2018-2024) & (US$ Million)
Table 33. Global Antihemophilic Factor Drug Revenue Share by Company (2018-2024)
Table 34. Global Market Antihemophilic Factor Drug Price by Company (2018-2024) & (USD/Unit)
Table 35. Global Antihemophilic Factor Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 36. Global Antihemophilic Factor Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 37. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antihemophilic Factor Drug as of 2022)
Table 38. Date of Key Manufacturers Enter into Antihemophilic Factor Drug Market
Table 39. Key Manufacturers Antihemophilic Factor Drug Product Type
Table 40. Mergers & Acquisitions, Expansion Plans
Table 41. Global Antihemophilic Factor Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 42. Global Antihemophilic Factor Drug Sales by Region (2018-2024) & (K Units)
Table 43. Global Antihemophilic Factor Drug Sales Market Share in Volume by Region (2018-2024)
Table 44. Global Antihemophilic Factor Drug Sales by Region (2018-2024) & (US$ Million)
Table 45. Global Antihemophilic Factor Drug Sales Market Share in Value by Region (2018-2024)
Table 46. Global Antihemophilic Factor Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 47. Global Antihemophilic Factor Drug Sales by Region (2024-2029) & (K Units)
Table 48. Global Antihemophilic Factor Drug Sales Market Share in Volume by Region (2024-2029)
Table 49. Global Antihemophilic Factor Drug Sales by Region (2024-2029) & (US$ Million)
Table 50. Global Antihemophilic Factor Drug Sales Market Share in Value by Region (2024-2029)
Table 51. Global Antihemophilic Factor Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 52. Global Antihemophilic Factor Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 53. Global Antihemophilic Factor Drug Sales by Application (2018-2024) & (K Units)
Table 54. Global Antihemophilic Factor Drug Sales Market Share in Volume by Application (2018-2024)
Table 55. Global Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 56. Global Antihemophilic Factor Drug Sales Market Share in Value by Application (2018-2024)
Table 57. Global Antihemophilic Factor Drug Price by Application (2018-2024) & (USD/Unit)
Table 58. Global Antihemophilic Factor Drug Sales by Application (2024-2029) & (K Units)
Table 59. Global Antihemophilic Factor Drug Sales Market Share in Volume by Application (2024-2029)
Table 60. Global Antihemophilic Factor Drug Sales by Application (2024-2029) & (US$ Million)
Table 61. Global Antihemophilic Factor Drug Sales Market Share in Value by Application (2024-2029)
Table 62. Global Antihemophilic Factor Drug Price by Application (2024-2029) & (USD/Unit)
Table 63. North America Antihemophilic Factor Drug Sales by Application (2018-2024) (K Units)
Table 64. North America Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Europe Antihemophilic Factor Drug Sales by Application (2018-2024) (K Units)
Table 66. Europe Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Asia-Pacific Antihemophilic Factor Drug Sales by Application (2018-2024) (K Units)
Table 68. Asia-Pacific Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. Latin America Antihemophilic Factor Drug Sales by Application (2018-2024) (K Units)
Table 70. Latin America Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 71. Middle East and Africa Antihemophilic Factor Drug Sales by Application (2018-2024) (K Units)
Table 72. Middle East and Africa Antihemophilic Factor Drug Sales by Application (2018-2024) & (US$ Million)
Table 73. North America Antihemophilic Factor Drug Sales by Country (2018-2024) & (K Units)
Table 74. North America Antihemophilic Factor Drug Sales Market Share in Volume by Country (2018-2024)
Table 75. North America Antihemophilic Factor Drug Sales by Country (2018-2024) & (US$ Million)
Table 76. North America Antihemophilic Factor Drug Sales Market Share in Value by Country (2018-2024)
Table 77. North America Antihemophilic Factor Drug Sales by Country (2024-2029) & (K Units)
Table 78. North America Antihemophilic Factor Drug Sales Market Share in Volume by Country (2024-2029)
Table 79. North America Antihemophilic Factor Drug Sales by Country (2024-2029) & (US$ Million)
Table 80. North America Antihemophilic Factor Drug Sales Market Share in Value by Country (2024-2029)
Table 81. Europe Antihemophilic Factor Drug Sales by Country (2018-2024) & (K Units)
Table 82. Europe Antihemophilic Factor Drug Sales Market Share in Volume by Country (2018-2024)
Table 83. Europe Antihemophilic Factor Drug Sales by Country (2018-2024) & (US$ Million)
Table 84. Europe Antihemophilic Factor Drug Sales Market Share in Value by Country (2018-2024)
Table 85. Europe Antihemophilic Factor Drug Sales by Country (2024-2029) & (K Units)
Table 86. Europe Antihemophilic Factor Drug Sales Market Share in Volume by Country (2024-2029)
Table 87. Europe Antihemophilic Factor Drug Sales by Country (2024-2029) & (US$ Million)
Table 88. Europe Antihemophilic Factor Drug Sales Market Share in Value by Country (2024-2029)
Table 89. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2018-2024) & (K Units)
Table 90. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Volume by Region (2018-2024)
Table 91. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2018-2024) & (US$ Million)
Table 92. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Value by Region (2018-2024)
Table 93. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2024-2029) & (K Units)
Table 94. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Volume by Region (2024-2029)
Table 95. Asia-Pacific Antihemophilic Factor Drug Sales by Region (2024-2029) & (US$ Million)
Table 96. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Value by Region (2024-2029)
Table 97. Latin America Antihemophilic Factor Drug Sales by Country (2018-2024) & (K Units)
Table 98. Latin America Antihemophilic Factor Drug Sales Market Share in Volume by Country (2018-2024)
Table 99. Latin America Antihemophilic Factor Drug Sales by Country (2018-2024) & (US$ Million)
Table 100. Latin America Antihemophilic Factor Drug Sales Market Share in Value by Country (2018-2024)
Table 101. Latin America Antihemophilic Factor Drug Sales by Country (2024-2029) & (K Units)
Table 102. Latin America Antihemophilic Factor Drug Sales Market Share in Volume by Country (2024-2029)
Table 103. Latin America Antihemophilic Factor Drug Sales by Country (2024-2029) & (US$ Million)
Table 104. Latin America Antihemophilic Factor Drug Sales Market Share in Value by Country (2024-2029)
Table 105. Middle East and Africa Antihemophilic Factor Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Volume by Country (2018-2024)
Table 107. Middle East and Africa Antihemophilic Factor Drug Sales by Country (2018-2024) & (US$ Million)
Table 108. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Value by Country (2018-2024)
Table 109. Middle East and Africa Antihemophilic Factor Drug Sales by Country (2024-2029) & (K Units)
Table 110. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Volume by Country (2024-2029)
Table 111. Middle East and Africa Antihemophilic Factor Drug Sales by Country (2024-2029) & (US$ Million)
Table 112. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Value by Country (2024-2029)
Table 113. Bayer Company Information
Table 114. Bayer Introduction and Business Overview
Table 115. Bayer Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 116. Bayer Antihemophilic Factor Drug Product
Table 117. Bayer Recent Development
Table 118. Takeda Company Information
Table 119. Takeda Introduction and Business Overview
Table 120. Takeda Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 121. Takeda Antihemophilic Factor Drug Product
Table 122. Takeda Recent Development
Table 123. Novo Nordisk Company Information
Table 124. Novo Nordisk Introduction and Business Overview
Table 125. Novo Nordisk Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 126. Novo Nordisk Antihemophilic Factor Drug Product
Table 127. Novo Nordisk Recent Development
Table 128. Pfizer Company Information
Table 129. Pfizer Introduction and Business Overview
Table 130. Pfizer Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 131. Pfizer Antihemophilic Factor Drug Product
Table 132. Pfizer Recent Development
Table 133. Grifols Company Information
Table 134. Grifols Introduction and Business Overview
Table 135. Grifols Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 136. Grifols Antihemophilic Factor Drug Product
Table 137. Grifols Recent Development
Table 138. CSL Behring Company Information
Table 139. CSL Behring Introduction and Business Overview
Table 140. CSL Behring Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 141. CSL Behring Antihemophilic Factor Drug Product
Table 142. CSL Behring Recent Development
Table 143. Sanofi Company Information
Table 144. Sanofi Introduction and Business Overview
Table 145. Sanofi Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 146. Sanofi Antihemophilic Factor Drug Product
Table 147. Sanofi Recent Development
Table 148. Cigna Company Information
Table 149. Cigna Introduction and Business Overview
Table 150. Cigna Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 151. Cigna Antihemophilic Factor Drug Product
Table 152. Cigna Recent Development
Table 153. Octapharma Company Information
Table 154. Octapharma Introduction and Business Overview
Table 155. Octapharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 156. Octapharma Antihemophilic Factor Drug Product
Table 157. Octapharma Recent Development
Table 158. GC Pharma Company Information
Table 159. GC Pharma Introduction and Business Overview
Table 160. GC Pharma Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 161. GC Pharma Antihemophilic Factor Drug Product
Table 162. GC Pharma Recent Development
Table 163. Hualan Biological Engineering Company Information
Table 164. Hualan Biological Engineering Introduction and Business Overview
Table 165. Hualan Biological Engineering Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 166. Hualan Biological Engineering Antihemophilic Factor Drug Product
Table 167. Hualan Biological Engineering Recent Development
Table 168. Shanghai RAAS blood products Company Information
Table 169. Shanghai RAAS blood products Introduction and Business Overview
Table 170. Shanghai RAAS blood products Antihemophilic Factor Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 171. Shanghai RAAS blood products Antihemophilic Factor Drug Product
Table 172. Shanghai RAAS blood products Recent Development
Table 173. Key Raw Materials Lists
Table 174. Raw Materials Key Suppliers Lists
Table 175. Antihemophilic Factor Drug Market Trends
Table 176. Antihemophilic Factor Drug Market Drivers
Table 177. Antihemophilic Factor Drug Market Challenges
Table 178. Antihemophilic Factor Drug Market Restraints
Table 179. Antihemophilic Factor Drug Distributors List
Table 180. Antihemophilic Factor Drug Downstream Customers
Table 181. Research Programs/Design for This Report
Table 182. Key Data Information from Secondary Sources
Table 183. Key Data Information from Primary Sources
List of Figures
Figure 1. Antihemophilic Factor Drug Product Picture
Figure 2. Global Antihemophilic Factor Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antihemophilic Factor Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Antihemophilic Factor Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 250 IU
Figure 6. Global 250 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 500 IU
Figure 8. Global 500 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of 1000 IU
Figure 10. Global 1000 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of 1500 IU
Figure 12. Global 1500 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Product Picture of 2000 IU
Figure 14. Global 2000 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 15. Product Picture of 3000 IU
Figure 16. Global 3000 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 17. Product Picture of 4000 IU
Figure 18. Global 4000 IU Sales YoY Growth (2018-2029) & (K Units)
Figure 19. Product Picture of Other potencies
Figure 20. Global Other potencies Sales YoY Growth (2018-2029) & (K Units)
Figure 21. Global Antihemophilic Factor Drug Sales by Type (2018-2029) & (US$ Million)
Figure 22. Global Antihemophilic Factor Drug Sales Market Share by Type in 2022 & 2029
Figure 23. North America Antihemophilic Factor Drug Sales Market Share in Volume by Type in 2022
Figure 24. North America Antihemophilic Factor Drug Sales Market Share in Value by Type in 2022
Figure 25. Europe Antihemophilic Factor Drug Sales Market Share in Volume by Type in 2022
Figure 26. Europe Antihemophilic Factor Drug Sales Market Share in Value by Type in 2022
Figure 27. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Volume by Type in 2022
Figure 28. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Value by Type in 2022
Figure 29. Latin America Antihemophilic Factor Drug Sales Market Share in Volume by Type in 2022
Figure 30. Latin America Antihemophilic Factor Drug Sales Market Share in Value by Type in 2022
Figure 31. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Volume by Type in 2022
Figure 32. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Value by Type in 2022
Figure 33. The 5 and 10 Largest Manufacturers in the World: Market Share by Antihemophilic Factor Drug Sales in 2022
Figure 34. The 5 and 10 Largest Manufacturers in the World: Market Share by Antihemophilic Factor Drug Revenue in 2022
Figure 35. Antihemophilic Factor Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 36. Product Picture of Adult
Figure 37. Global Adult Sales YoY Growth (2018-2029) & (K Units)
Figure 38. Product Picture of Pediatric
Figure 39. Global Pediatric Sales YoY Growth (2018-2029) & (K Units)
Figure 40. Global Antihemophilic Factor Drug Sales by Application (2018-2029) & (US$ Million)
Figure 41. Global Antihemophilic Factor Drug Sales Market Share by Application in 2022 & 2029
Figure 42. North America Antihemophilic Factor Drug Sales Market Share in Volume by Application in 2022
Figure 43. North America Antihemophilic Factor Drug Sales Market Share in Value by Application in 2022
Figure 44. Europe Antihemophilic Factor Drug Sales Market Share in Volume by Application in 2022
Figure 45. Europe Antihemophilic Factor Drug Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Antihemophilic Factor Drug Sales Market Share in Value by Application in 2022
Figure 48. Latin America Antihemophilic Factor Drug Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Antihemophilic Factor Drug Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Antihemophilic Factor Drug Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Antihemophilic Factor Drug Manufacturing Cost Structure
Figure 53. Antihemophilic Factor Drug Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries